Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 2057 - 2064 of 12011 results
NYC Proposes Rules in Advance of 2023 Automated Employment Decision Tools Law
November 4, 2022| Blog| Viewpoint
Last Call: Public Comments on Inflation Reduction Act Clean Energy Tax Incentives Are Requested By November 4
November 3, 2022| Alert| Viewpoint
RIAs Beware: The Pitfalls When Going Straight To The (Out)Source
November 3, 2022| Blog| Viewpoint
Connecticut Joins the Interstate Medical Licensure Compact and the Psychology Interjurisdictional Compact
November 3, 2022| Blog| Viewpoint
Ruling May Spur New Patent Venue Rows Over Remote Work
November 3, 2022| News
Mintz Attorneys Help Fuel Equitable Growth at the Bizgrow Conference
November 2, 2022| Article| Viewpoint
SEC Adopts Amendments Requiring Electronic Filing of Forms 144
November 2, 2022| Alert| Viewpoint
What's New in 5G - November 2022
November 2, 2022| Blog| Viewpoint
News & Press Releases
Mintz advised The Eagle Leasing Company, a leading provider of portable storage containers, ground level offices, semi-trailers, and mobile office solutions, in its acquisition by Rent-A-Container (RAC), a portfolio company of Kinderhook Industries, LLC.
Mintz’s Life Sciences practice has been shortlisted in multiple categories for the 2025 LMG Life Sciences Americas Awards. The winners will be announced at an awards ceremony in New York on September 4. In the United States, Mintz was shortlisted in the “Venture Capital Firm of the Year” category. In Canada, Mintz was shortlisted in the “Financial & Corporate Firm of the Year” and “Patent Strategy Firm of the Year” categories.
Mintz advised ArriVent BioPharma, Inc., a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers, on a $75 million underwritten public offering of 2,482,692 shares of its common stock and pre-funded warrants to purchase up to 1,363,469 shares of its common stock. The common stock is listed on The Nasdaq Global Market under the symbol “AVBP.“
Events
Mintz x The Engine: Supercharging Your IP Strategy with Trade Secrets
The Engine, 750 Main St. Cambridge, MA 02139
Podcasts
Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|
Mintz On Air: Practical Policies – An Abridged Guide to Crisis Management
July 1, 2025| Podcast|